| Predictors | Outcome | CHR (95% CI) | p value | AHR (95% CI) | p value |
|---|
| Died | Censored |
|---|
| Age | 48 | 452 | 1.05 (1.01–1.08) | 0.002 | 1.05 (1.01–1.08) | 0.008 |
| Sex |
| Male | 20 | 144 | 1 | | | |
| Female | 28 | 308 | 1.54 (1.13–2.08) | 0.006 | | |
| Residence |
| Rural | 36 | 184 | 2.7 (1.73–4.2) | 0.000 | 2.42 (1.5–3.8) | 0.000 |
| Urban | 12 | 268 | 1 | | 1 | |
| Marital status | | | | | | |
| Single | 4 | 74 | 1 | | | |
| Married | 22 | 242 | 0.78 (0.47–1.08) | 0.3 | – | |
| Divorced | 22 | 136 | 1.01 (0.92–1.21) | 0.26 | – | |
| Educational status |
| Illiterate | 26 | 168 | 1.35 (0.99,1.83) | 0.05 | – | |
| Literate | 22 | 294 | 1 | | | |
| Weight | 48 | 452 | 0.95 (0.94–1.06) | 0.9 | – | |
| WHO stage |
| Stage I | 4 | 114 | 1 | | | |
| Stage II | 4 | 124 | 1.04 (0.13–5.3) | 0.8 | – | |
| Stage III | 38 | 192 | 1.05 (0.12–4.1) | 0.7 | – | |
| Stage IV | 2 | 22 | 1.1 (0.2–6.1) | 0.9 | – | |
| Program |
| UTT | 12 | 192 | 1 | | 1 | |
| Differed | 36 | 260 | 3.45 (1.7–7.2) | 0.001 | 4.13 (1.86–9.17) | 0.000 |
| New OIS |
| Yes | 12 | 28 | 2.87 (2.03–4.07) | 0.000 | 3.66 (2.4–5.6) | 0.000 |
| No | 36 | 424 | 1 | | 1 | |
| Treatment failure |
| Yes | 18 | 12 | 11.34 (5.8–22) | | 3.8 (1.8–8.4) | 0.000 |
| No | 30 | 440 | 1 | | 1 | |
| Treatment switch |
| Yes | 2 | 6 | 1.2 (0.6–2.5) | 0.6 | – | |
| No | 46 | 446 | 1 | | | |
| Base line CD4 count | 48 | 452 | 0.99 (0.99–1.1) | 0.06 | 0.996 (0.993–0.999) | 0.017 |
